Purchase Order 36C24225P1301
Award Date
8/4/25
Potential Completion Date
8/8/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 2
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Belle Isle, FL 32809, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the emergency supply of the prescription drug Jynarque (tolvaptan) for $13,242.99, with a completion date of August 4, 2025. Jynarque is used to treat autosomal dominant polycystic kidney disease. This non-set-aside contract was awarded through the VA's Veterans Integrated Service Network 2...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a division of the larger Walgreens retail pharmacy chain. The $12,580.72 firm fixed price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to VA facilities. Jynarque is used to treat autosomal dominant polycystic kidney disease. This contract does not have a set-aside designation and is part of...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $83,000.32, is for the supply of the pharmaceutical drug JYNARQUE (tolvaptan) to treat autosomal dominant polycystic kidney disease. The contract does not have a set-aside designation and has an ultimate completion date of September 30, 2021. Walgreens...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The...
This is a federal contract award with the ID 36C24225P0419, issued by the U.S. Department of Veterans Affairs (VA) to the prime contractor Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the supply of the pharmaceutical product Jynarque (tolvaptan) 45mg/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract is a firm fixed price purchase order with a ceiling value of $13,242.99 and an ultimate completion date of...
This is a firm fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain. The $12,580.72 contract is for the supply of Jynarque 45mg/15mg tablets, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease. The contract has a performance period from June 5, 2024 to September 5, 2024 and was not set aside for...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the emergency supply of the prescription drug Jynarque (tolvaptan) to the Northport VA Medical Center. The contract has a ceiling value of $13,242.99 and a performance period ending on July 21, 2025. The contract was awarded on July 7, 2025 and does not have a...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) tablets to the VA's Veterans Integrated Service Network 2 (VISN 2) facilities. The contract has a ceiling value of $13,242.99 and a period of performance through August 27, 2025. The contract does not...
This is a $13,242.99 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) to the VA's Veterans Integrated Service Network 2 (VISN 2). The award has no set-aside designation, indicating it is open to all qualified vendors. The performance period runs from the award date of April 30, 2025 through the...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Walgreens Specialty Pharmacy, LLC in the amount of $12,580.72. The contract is for the delivery of the medication Jynarque (tolvaptan) to treat autosomal dominant polycystic kidney disease. This contract was awarded to Walgreens Specialty Pharmacy as the prime contractor, with no set-aside designation mentioned. The contract period of performance runs through March 19,...